Report #2829486

Overview

Sex

Male

Age

Age unknown

State

MT

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

The patient took a partial dosage of Vivotif; took one or two pills of Vivotif which were prescribed three weeks ago; Case reference number US-BN-2024-000606 is a spontaneous case report initially received from a nurse via Med Communications (reference number: USBAV24-0448) on 05-Mar-2024 and concerns a 16-year-old male patient. The patient's medical history and concomitant medication details were not provided. On an unknown date, the patient took a dose of Vivotif (batch number: unknown), orally, at an unknown dose, for typhoid prophylaxis. As reported, the patient was seen in the clinic three weeks ago (on the 14th), when they were prescribed with Vivotif and the patient took one or two pills (explicitly coded as 'Inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Additional information received from the reporter via Med Communications on 06-Mar-2024: included confirmation of patient's gender and that patient took one or two pills.; Reporter's Comments: A 16-year-old male patient took a dose of Vivotif orally, at an unknown dose, for typhoid prophylaxis. Reportedly, the patient was seen in the clinic three weeks ago, when they were prescribed with Vivotif and the patient took one or two pills which is currently considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 16-year-old male patient took a dose of Vivotif orally, at an unknown dose, for typhoid prophylaxis. Reportedly, the patient was seen in the clinic three weeks ago, when they were prescribed with Vivotif and the patient took one or two pills which is currently considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.

Medical history

Comments: None.